Companies: 10,795·Total market cap: $144.5T
SeqLL Inc.

SeqLL Inc.

SQLNASDAQHealthcare
$6.60
$-0.16(-2.38%)
Market Cap$2511934
P/E Ratio
52W High$6.76
52W Low$6.76
Overview

SeqLL Inc. (SQL) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

sql · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for SeqLL Inc. (SQL) measures how much investors pay for each dollar of the company's trailing earnings. SQL's current PE ratio of N/A is calculated by dividing its stock price of $6.60 by its TTM earnings per share of -$108.36.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2025 est. EPS $-18.40
Based on 1 analyst
EPS (TTM)
-$108.36
TTM · diluted EPS
PEG Ratio
-0.00
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · SeqLL Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2016 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Diagnostics & Research · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
SeqLL Inc.
SeqLL Inc.You
SQL
$3MN/A-$108.36
Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc.
APDN
$7MN/A-$134.23
Athenex, Inc.
Athenex, Inc.
ATNX
$2MN/A-$15.13
Aspira Women's Health Inc.
Aspira Women's Health Inc.
AWH
$2MN/A-$0.37
Biophytis S.A.
Biophytis S.A.
BPTS
$3MN/A-$12.55
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc.
EIGRQ
$13MN/A-$50.78
Vyome Holdings, Inc.
Vyome Holdings, Inc.
HIND
$12MN/A-$4.75

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 9 of 9 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1.08
2024-12-31
FY2024
$-3.68
2022-12-31
FY2022
$-0.14
2021-12-31
FY2021
$-0.22
2020-12-31
FY2020
$-0.13
2019-12-31
FY2019
$-0.22
2018-12-31
FY2018
$-0.24
2017-12-31
FY2017
$-0.06
2016-12-31
FY2016
$-11.79

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for SeqLL Inc. (SQL) measures how much investors pay for each dollar of the company's trailing earnings. SQL's current PE ratio of N/A is calculated by dividing its stock price of $6.60 by its TTM earnings per share of -$108.36.

PE Ratio = Stock Price ÷ EPS (TTM)
= $6.60 ÷ -$108.36 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

SQL pe ratio · 6 questions

SQL's current PE ratio is N/A as of 2026-06-09, based on a stock price of $6.60 and TTM EPS of -$108.36. Data sourced from Financial Modeling Prep via SQL's SEC 10-K and 10-Q filings.

SQL PE ratioWhat is SQL PE ratioCurrent PE ratio of SQLSQL PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · SeqLL Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09